Jessica M Mast, CRNA | |
1500 E Medical Center Drive, 1h247 Unversity Hospital, Ann Arbor, MI 48109-4280 | |
(734) 936-4280 | |
(248) 849-5489 |
Full Name | Jessica M Mast |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 19 Years |
Location | 1500 E Medical Center Drive, Ann Arbor, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578668273 | NPI | - | NPPES |
4830020 | Medicaid | MI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 4704225322 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Michigan Health System | Ann arbor, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
With the first patient vaccinated, a Phase 2 clinical trial of a promising prophylactic vaccine candidate against Chikungunya fever has now commenced. The product is the most advanced Chikungunya vaccine candidate globally and is developed by the Austrian biotech company Themis Bioscience GmbH.
Placing medications as close as possible to the site of the disease: This sounds completely believable in theory, but is unfortunately not so simple in practice. While this works well for many drugs via the bloodstream or the digestive tract, it does not apply to the brain.
By adapting a single protein on the surface of the bacterium Caulobacter crescentus, researchers at the University of British Columbia have turned it into a protein production factory, making useful proteins that can act as vaccines and drugs. Dr. John Smit presented the findings at the Society for General Microbiology's meeting at Heriot-Watt University, Edinburgh, today (7 September).
A new technique for studying the lifecycle of the hepatitis B virus could help researchers develop a cure for the disease.
› Verified 6 days ago
Entity Name | Regents Of The University Of Michigan |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528010428 PECOS PAC ID: 3779496856 Enrollment ID: O20031121000336 |
News Archive
With the first patient vaccinated, a Phase 2 clinical trial of a promising prophylactic vaccine candidate against Chikungunya fever has now commenced. The product is the most advanced Chikungunya vaccine candidate globally and is developed by the Austrian biotech company Themis Bioscience GmbH.
Placing medications as close as possible to the site of the disease: This sounds completely believable in theory, but is unfortunately not so simple in practice. While this works well for many drugs via the bloodstream or the digestive tract, it does not apply to the brain.
By adapting a single protein on the surface of the bacterium Caulobacter crescentus, researchers at the University of British Columbia have turned it into a protein production factory, making useful proteins that can act as vaccines and drugs. Dr. John Smit presented the findings at the Society for General Microbiology's meeting at Heriot-Watt University, Edinburgh, today (7 September).
A new technique for studying the lifecycle of the hepatitis B virus could help researchers develop a cure for the disease.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Jessica M Mast, CRNA 3621 S State St, 700 Kms Place, Ann Arbor, MI 48108 Ph: (734) 936-2047 | Jessica M Mast, CRNA 1500 E Medical Center Drive, 1h247 Unversity Hospital, Ann Arbor, MI 48109-4280 Ph: (734) 936-4280 |
News Archive
With the first patient vaccinated, a Phase 2 clinical trial of a promising prophylactic vaccine candidate against Chikungunya fever has now commenced. The product is the most advanced Chikungunya vaccine candidate globally and is developed by the Austrian biotech company Themis Bioscience GmbH.
Placing medications as close as possible to the site of the disease: This sounds completely believable in theory, but is unfortunately not so simple in practice. While this works well for many drugs via the bloodstream or the digestive tract, it does not apply to the brain.
By adapting a single protein on the surface of the bacterium Caulobacter crescentus, researchers at the University of British Columbia have turned it into a protein production factory, making useful proteins that can act as vaccines and drugs. Dr. John Smit presented the findings at the Society for General Microbiology's meeting at Heriot-Watt University, Edinburgh, today (7 September).
A new technique for studying the lifecycle of the hepatitis B virus could help researchers develop a cure for the disease.
› Verified 6 days ago
Denise Lynn Berry, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Ashley Marie Dibardino, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Terrance Solan, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Paula K Globerson, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4280 | |
Lawrence R Stump, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4280 | |
Mary Catherine Downey, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Renee Ann Shea, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Drive, 1h247 University Hospital, Ann Arbor, MI 48109 Phone: 734-936-4280 |